228 related articles for article (PubMed ID: 9763199)
1. A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat.
Lehr JE; Pienta KJ; Yamazaki K; Pilat MJ
Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):949-59. PubMed ID: 9763199
[TBL] [Abstract][Full Text] [Related]
2. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
[TBL] [Abstract][Full Text] [Related]
3. Establishment of an immortalized Copenhagen rat prostate epithelial cell line.
Yamazaki K; Pienta KJ
In Vivo; 1995; 9(5):427-32. PubMed ID: 8900919
[TBL] [Abstract][Full Text] [Related]
4. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
5. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
Devi GR; Oldenkamp JR; London CA; Iversen PL
Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
[TBL] [Abstract][Full Text] [Related]
7. Regulation of C-myc and C-Ha-ras oncogene expression by cell shape.
Farrell RE; Greene JJ
J Cell Physiol; 1992 Nov; 153(2):429-35. PubMed ID: 1385453
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous metastasis of rat liver epithelial cells transformed with v-raf and v-raf/v-myc: association with different phenotypic properties.
Bisgaard HC; Mackay AR; Gomez DE; Ton PT; Thorgeirsson SS; Thorgeirsson UP
Invasion Metastasis; 1997; 17(5):240-50. PubMed ID: 9876218
[TBL] [Abstract][Full Text] [Related]
9. Resistance of murine LTA cells to oncogene--mediated progression from tumorigenic to metastatic phenotype.
Tuck AB; Wilson SM; Chambers AF
Anticancer Res; 1990; 10(6):1507-14. PubMed ID: 2285224
[TBL] [Abstract][Full Text] [Related]
10. Experimental oncogene induced prostate cancer.
Thompson TC; Kadmon D; Timme TL; Merz VW; Egawa S; Krebs T; Scardino PT; Park SH
Cancer Surv; 1991; 11():55-71. PubMed ID: 1726789
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA
Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192
[TBL] [Abstract][Full Text] [Related]
12. The multistage process of carcinogenesis in human esophageal epithelial cells induced by human papillomavirus.
Shen ZY; Xu LY; Li EM; Cai WJ; Shen J; Chen MH; Cen S; Tsao SW; Zeng Y
Oncol Rep; 2004 Mar; 11(3):647-54. PubMed ID: 14767516
[TBL] [Abstract][Full Text] [Related]
13. A novel neoplastic primary tumor-derived human prostate epithelial cell line.
Ko D; Gu Y; Yasunaga Y; Nakamura K; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Arnstein P; Taylor DO; Hukku B; Rhim JS
Int J Oncol; 2003 Jun; 22(6):1311-7. PubMed ID: 12738999
[TBL] [Abstract][Full Text] [Related]
14. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
[TBL] [Abstract][Full Text] [Related]
15. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
16. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
Xia W; Unger P; Miller L; Nelson J; Gelman IH
Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
[TBL] [Abstract][Full Text] [Related]
17. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
18. Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.
Pfeifer AM; Jones RT; Bowden PE; Mann D; Spillare E; Klein-Szanto AJ; Trump BF; Harris CC
Cancer Res; 1991 Jul; 51(14):3793-801. PubMed ID: 1712250
[TBL] [Abstract][Full Text] [Related]
19. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
20. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089.
Perez-Stable CM; Schwartz GG; Farinas A; Finegold M; Binderup L; Howard GA; Roos BA
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):555-63. PubMed ID: 12050097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
